We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Low Cylinder Toric

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00732030
First Posted: August 11, 2008
Last Update Posted: April 7, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Alcon Research
August 7, 2008
August 11, 2008
April 29, 2009
April 7, 2010
April 7, 2010
June 2007
March 2009   (Final data collection date for primary outcome measure)
  • Uncorrected Distance Visual Acuity [ Time Frame: 6 months ]
    Uncorrected Distance Visual Acuity at month 6 measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". It is a unit of measure for visual acuity (VA).
  • Best Corrected Distance Visual Acuity [ Time Frame: 6 Months ]
    Best Corrected Distance Visual Acuity at month 6 measured in LogMAR. LogMAR is the "logarithm of the minimum angle of resolution". It is a unit of measure for visual acuity (VA).
  • Residual Refractive Cylinder [ Time Frame: 6 Month ]
    Residual Refractive Cylinder at month 6 measured in diopters (D).
Visual Acuity, Residual Refractive Cylinder [ Time Frame: 6 Month ]
Complete list of historical versions of study NCT00732030 on ClinicalTrials.gov Archive Site
Patient Satisfaction Survey [ Time Frame: 6 months ]
Satisfaction for daytime distance vision, nighttime distance vision, and indoors distance vision on a scale of 1 to 5, with 1 being very dissatisfied and 5 being very satisfied.
Patient Satisfaction Survey [ Time Frame: 6 months ]
Not Provided
Not Provided
 
Low Cylinder Toric
Evaluation of the Acrysof Toric Model SN60T3 Intraocular Lens in Patients With Predicted Residual Corneal Astigmatism Between 0.75 and 1.03 Diopters (D)
Study evaluates the visual outcomes and patient satisfaction after implantation of a toric intraocular lens (IOL).
Not Provided
Interventional
Phase 4
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Cataracts
Device: Toric IOL (SN60T3)
Each enrolled eye implanted with the AcrySof Toric Model SN60T3 intraocular lens (IOL) for the treatment of cataract.
Experimental: AcrySof Toric T3
Each enrolled eye receives AcrySof Toric Model SN60T3 Intraocular Lens (IOL)
Intervention: Device: Toric IOL (SN60T3)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
26
Not Provided
March 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosed with Cataracts
  • Predicted residual corneal astigmatism between 0.75 and 1.03 Diopters (D)

Exclusion Criteria:

  • Preoperative ocular pathology
  • Planned monovision
Sexes Eligible for Study: All
21 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00732030
M07-005
No
Not Provided
Not Provided
Rick Potvin/Director - Global Scientific Market Affairs, Alcon Research
Alcon Research
Not Provided
Not Provided
Alcon Research
March 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP